Compare VIST & STVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | VIST | STVN |
|---|---|---|
| Founded | 2017 | 1949 |
| Country | Mexico | Italy |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Containers/Packaging |
| Sector | Energy | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.7B | 5.9B |
| IPO Year | 2019 | 2021 |
| Metric | VIST | STVN |
|---|---|---|
| Price | $74.71 | $20.69 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 3 |
| Target Price | ★ $81.33 | $25.67 |
| AVG Volume (30 Days) | ★ 976.5K | 413.4K |
| Earning Date | 04-29-2026 | 05-07-2026 |
| Dividend Yield | N/A | ★ 0.39% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $20.93 | $9.67 |
| Revenue Next Year | $20.35 | $9.99 |
| P/E Ratio | ★ $7.99 | $27.15 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $33.37 | $12.89 |
| 52 Week High | $81.44 | $28.00 |
| Indicator | VIST | STVN |
|---|---|---|
| Relative Strength Index (RSI) | 61.53 | 44.81 |
| Support Level | $62.32 | $20.17 |
| Resistance Level | $77.59 | $20.63 |
| Average True Range (ATR) | 2.82 | 0.74 |
| MACD | 0.68 | -0.26 |
| Stochastic Oscillator | 66.48 | 3.97 |
Vista Energy SAB de CV is an independent oil and gas company. It is focused on shale oil and shale gas exploration at its main assets in Vaca Muerta. The company has operations in Argentina and Mexico. The company operates in a single segment- the exploration and production of Crude oil, Natural gas, and LPG. Geographically, it operates in Argentina and Mexico. Product-wise, the firm generates the majority of its revenue from crude oil sales, natural gas sales, and LPG sales.
Stevanato Group is a provider of glass and polymer drug containment, drug delivery, and diagnostic solutions to the pharmaceutical and life sciences industries. The company operates through two segments: a Biopharmaceutical and Diagnostic Solutions segment, which offers an integrated, end-to-end portfolio of products, processes, and services spanning the full drug lifecycle; and an Engineering segment, which designs, develops, and manufactures advanced machinery for pharmaceutical manufacturing, covering visual inspection, assembly and packaging, glass converting, and serialization. Stevanato's revenue is geographically diversified, with approximately 60% of sales generated in Europe, the Middle East, and Africa, 30% in North America, 8% in Asia-Pacific, and 2% in South America.